Suzette Dimascio CHE, CMCE, CPC

Suzette DiMascio, CHE, CMCE, CPC is President/CEO of the CSI Specialty Group, a globally recognized Leadership Consulting Firm helping clients drive sustainable, accelerated growth. Recognized Internationally as a thought leader, industry expert, frequent media contributor, sought after speaker & educator of all things related to the Specialty Pharmacy / rare and orphan disease arena; Suzette’s strategic insight on marketplace trends help align & enlighten this continually pivoting industry. Under Suzette’s leadership, CSI Specialty Group has become the industry’s preeminent Leadership Consulting firm; offering strategic solutions to all healthcare market channels across the spectrum from IDNs & Health Systems to Manufacturers. Recent honors include being named one of Consulting Magazine’s Fastest Growing Firms, Goldman Sachs Top Growing Businesses & Top 50 Women Owned Business by Commonwealth Institute. Suzette received APPA’s Hall of Fame Award– given as a reflection of her dedication to the industry & passion for patient care- as it is at the forefront in all programs CSI develops to support their client’s endeavors to improve patient lives. She’s been Instrumental in positioning CSI as a respected resource for educational programs, as well as starting the industry’s first dedicated podcast, focused on uncovering ways to make the specialty pharmacy journey more successful for patients worldwide.

CSI has been Integral in the start-up of many national sites, including Aetna Specialty Pharmacy, Humana’s Right Source Specialty Pharmacy, Kedrion BioPharma, Johns Hopkins Specialty Pharmacy, and QOL Medical Biopharma Hub Services. Prior to starting CSI in 2002, Suzette held senior leadership roles within the Specialty Pharmacy & Biotech industry, with NMC Home Infusion, Pfizer and Nestle Life Sciences. She brings particular expertise in Managed Care & Payor Strategies, Sales Leadership, Reimbursement, Human Resources, Startups and Overall Specialty Pharmacy Market Strategy. Suzette is also a pioneer in the Disease Management and Tele-Health industry –and actually also holds a patent in this arena.